Sep 07, 2023 / 02:30PM GMT
Andrew Simon Baum - Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
So delighted to introduce Mikael Dolsten. Mikael is President, R&D, Chief Scientific Officer. Did I miss any other title?
Mikael Dolsten - Pfizer Inc. - Chief Scientific Officer and President of Research & Development
You did it very well.
Andrew Simon Baum - Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
That's it. And also Chris Stevo, the Head of IR; and then we have several other members of the Pfizer team with us today. So obviously, there's a lot of change going on -- oh, sorry, forgive me. Chris is going to make some opening comments. Then he's going to pass it to Mikael. Then I'll ask the question.
Christopher J. Stevo - Pfizer Inc. - Senior VP & Chief IR Officer
So this is going to be very scintillating and interesting for all of you. I can assure you of that. In the course of this presentation, Mikael might make some forward
Pfizer Inc at Citi BioPharma Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers